Glutamate administration in neonatal rats causes reversible changes in blood–brain barrier
(BBB) permeability and known neurotoxic lesions. This study was aimed to evaluate whether …

This review assesses many of the health implications and toxicity associated with
monosodium glutamate (MSG) in animal models. MSG is the sodium salt of the amino acid …

Glutamate is the principal excitatory amino acid neurotransmitter abundantly present in the
brain of mammals, as well as in dietary protein, released by an estimated 40% of all …

Monosodium glutamate (MSG), a food flavor enhancer used worldwide, has been studied
because it may cause neurotoxicity, which is associated with oxidative stress. The aim of this …

Monosodium glutamate (MSG) is a neuroexcitatory amino acid commonly used as flavoring
of foods. MSG neonatal administration to animals leads to behavioral and physiological …

The present study evaluated long-term behavioral consequences of neonatal monosodium-l-
glutamate (MSG) treatment in rats. The pups received MSG (3 mg/g sc) daily from postnatal …

The metabolic syndrome is a group of metabolic alterations considered a worldwide public
health problem. Organic selenium compounds have been reported to have many different …

Obesity is a chronic and complex medical condition characterized by excessive fat
accumulation and its complications include metabolic syndrome, diabetes and chronic …

Monosodium glutamate (MSG) treatment of neonatal rodents leads to degeneration of the
neurons in the arcuate nucleus, inner retinal layers and various other brain areas. It also …

Monosodium glutamate (MSG) treatment of neonatal rats causes neuronal degeneration in
various brain areas and leads to several neurochemical, endocrinological and behavioral …